ReviewMicrobial cell factories2026
Modular biosynthesis of microbiome-derived polyketides and nonribosomal peptides: insights and opportunities for Lactobacillaceae.
Review in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Lactobacillaceae are a heterogeneous group of Gram-positive bacteria that play key roles in microbiome-dense ecosystems, particularly in mucosal habitats such as the vagina and gut, as well as in fermented foods. Widely recognized for their beneficial properties and broad applicability, they are best known for producing lactic acid and other small carboxylic acids. In contrast, their capacity to produce specialized metabolites, especially nonribosomal peptides and polyketides, has remained underexplored. These compounds, traditionally studied in soil-dwelling bacteria, are often assembled by large, multi-modular enzyme complexes, and include molecules with antibiotic, immunomodulatory and anticancer activities. Recent genomic surveys revealed that, despite their smaller genomes, Lactobacillaceae harbor numerous biosynthetic gene clusters encoding these metabolites, though only a handful has been experimentally characterized to date. Interestingly, the characterized examples display unusual domain architectures, atypical biosynthetic pathways, and novel chemical transformations. This review synthesizes current knowledge on the diversity, biosynthetic pathways and functional roles of specialized metabolites in Lactobacillaceae, and highlights their largely underexplored potential as one of the most important health-associated bacterial families known to date. Revealing their chemical repertoire not only expands our understanding of microbial specialized metabolism but also defines their roles in food preservation, plant health, and in preventing and treating infections across microbiome-rich mucosal ecosystems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.